- Home
- VEEE vs CDT Comparison
VEEE vs CDT Comparison
Compare VEEE & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEEE
- CDT
- Stock Information
- Founded
- VEEE 1994
- CDT 2019
- Country
- VEEE United States
- CDT United States
- Employees
- VEEE N/A
- CDT N/A
- Industry
- VEEE Marine Transportation
- CDT Biotechnology: Pharmaceutical Preparations
- Sector
- VEEE Industrials
- CDT Health Care
- Exchange
- VEEE Nasdaq
- CDT Nasdaq
- Market Cap
- VEEE 5.8M
- CDT 5.2M
- IPO Year
- VEEE 2021
- CDT N/A
- Fundamental
- Price
- VEEE $2.10
- CDT $1.85
- Analyst Decision
- VEEE
- CDT
- Analyst Count
- VEEE 0
- CDT 0
- Target Price
- VEEE N/A
- CDT N/A
- AVG Volume (30 Days)
- VEEE 133.2K
- CDT 119.6K
- Earning Date
- VEEE 08-07-2025
- CDT 08-19-2025
- Dividend Yield
- VEEE N/A
- CDT N/A
- EPS Growth
- VEEE N/A
- CDT N/A
- EPS
- VEEE N/A
- CDT N/A
- Revenue
- VEEE $13,153,262.00
- CDT N/A
- Revenue This Year
- VEEE N/A
- CDT N/A
- Revenue Next Year
- VEEE N/A
- CDT N/A
- P/E Ratio
- VEEE N/A
- CDT N/A
- Revenue Growth
- VEEE N/A
- CDT N/A
- 52 Week Low
- VEEE $1.88
- CDT $1.70
- 52 Week High
- VEEE $9.30
- CDT $622.50
- Technical
- Relative Strength Index (RSI)
- VEEE 40.77
- CDT 31.52
- Support Level
- VEEE $2.08
- CDT $1.94
- Resistance Level
- VEEE $2.72
- CDT $1.90
- Average True Range (ATR)
- VEEE 0.21
- CDT 0.11
- MACD
- VEEE 0.00
- CDT 0.04
- Stochastic Oscillator
- VEEE 26.18
- CDT 27.27
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power boats to use for fishing, diving and water skiing, and commercial activities including transportation, eco-tours, fishing, and diving expeditions. The company offers various boat models, including Twin Vee 400 GFX2 CC, Twin Vee 280 GFX2 CC, and Twin Vee 260 Center Console STX, among others. Its products are marketed under two brands, Twin Vee for its catamarans, or dual-hull vessels, and Aquasport for its V-hull boats. The company sells its boats through a network of independent boat dealers across North America, the Caribbean, and Central America who resell the boats to the end user, Twin Vee customers.
About CDT Conduit Pharmaceuticals Inc.
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.